Prolactin as a mitogen in mammary cells

Journal of Mammary Gland Biology and Neoplasia

Volumn 2, Issue 1, 1997, Pages 29-39

  Das, Rina ^a   Vonderhaar, Barbara K ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Bldg 10 ^*  (United States)

Author keywords

Breast cancer; Mitogenesis; Normal mammary gland development; Prolactin; Receptor forms; Signal pathways

Indexed keywords

MITOGENIC AGENT; PROLACTIN; PROLACTIN RECEPTOR; PROTEIN; PROTEIN KINASE C; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SRC HOMOLOGY 2 DOMAIN CONTAINING, TRANSFORMING PROTEIN 1; SRC HOMOLOGY 2 DOMAIN-CONTAINING, TRANSFORMING PROTEIN 1; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ANIMAL; BREAST; BREAST TUMOR; CYTOLOGY; HUMAN; PATHOLOGY; PHYSIOLOGY; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; UDDER;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; BREAST; BREAST NEOPLASMS; HUMANS; MAMMARY GLANDS, ANIMAL; MAP KINASE SIGNALING SYSTEM; MITOGENS; PROLACTIN; PROTEIN KINASE C; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; RECEPTORS, PROLACTIN;

EID: 0030621513     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026369412612     Document Type: Article

References (68)

1. B. K. Vonderhaar (1987). Prolactin: transport, function, and receptors in mammary gland development and differentiation. In M. C. Neville and C. W. Daniel (eds.), The Mammary Gland, Plenum Publishing Corp., New York, pp. 383-438.
2. Y. N. Sinha (1995). Structural variants of prolactin: Occurrence and physiological significance. Endocrine Reviews 16:354-369.
3. E. Ginsburg and B. K. Vonderhaar (1995). Prolactin synthesis and secretion by human breast cancer cells. Cancer Res. 55:2591-2595.
4. C. V. Clevenger and T. L. Plank (1997). Prolactin as an autocrine/paracrine factor in breast tissue. J. Mam. Gland Biol. Neoplasia 2(1):59-68.
5. B. K. Vonderhaar and R. Biswas (1987). Prolactin effects and regulation of its receptors in human mammary tumor cells. In D. Medina, W. Kidwell, G. Hepner, and E. Anderson (eds.), Cellular and Molecular Biology of Mammary Cancer, Plenum Publishing Corp., New York, pp. 205-219.
6. J. Mershon, W. Salt, N. Mitchner, and N. Ben-Jonathan (1995). Prolactin is a local growth factor in rat mammary tumors. Endocrinology 136:3619-3623.
7. C. Welsch and H. Nagasawa (1977). Prolactin and murine mammary tumorigenesis: a review. Cancer Res. 37:951-963.
8. W. Holtkamp, G. A. Nagel, H. E. Wander, H. F. Rauschecker, and D. VonHeyden (1984). Hyperprolactenemia is an indicator of progressive disease and poor prognosis in advanced breast cancer. Int. J. Cancer. 34:323-328.
9. H. Nagasawa, K. Miur, K. Niki, and H. Namiki (1985). Interrelationship between prolactin and progesterone in normal mammary gland growth in SHN virgin mice. Exp. Clin. Endocrinol. 86:357-360.
10. K. Plaut, M. Ikeda, and B. K. Vonderhaar (1993). Role of growth hormone and insulin-like growth factor 1 in mammary development. Endocrinology 133:1843-1848.
11. C. S. Atwood, M. Ikeda, and B. K. Vonderhaar (1995). Involution of mouse mammary glands in whole organ culture: a model for studying programmed cell death. Biochem. Biophys. Res. Commun. 207:860-867.
12. R. Banerjee and B. K. Vonderhaar (1992). Prolactin induced protein kinase C activity in a mouse mammary epithelial cell line NOG-8. Mol. Cell. Endocrinol. 90:61-67.
13. R. R. Love, D. R. Rose, T. S. Surawicz, and P. A. Newcomb (1991). Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with a strong family history of breast cancer. Cancer 68:1401-1405.
14. W. B. Malarkey, M. Kennedy, L. E. Allred, and G. Milo (1983). Physiological concentrations of prolactin can promote the growth of human breast tumor cells in culture. J. Clin. Endocrinol. Metab. 56:673-677.
15. R. Biswas and B. K. Vonderhaar (1987). Role of serum in prolactin responsiveness of MCF-7 human breast cancer cells in long term tissue culture. Cancer Res. 47:3509-3514.
16. R. Das, E. Ginsburg, and B. K. Vonderhaar (1994). Tamoxifen as an antilactogen in human breast cancer cells. In R. S. Rao, M. G. Deo, L. D. Sanghvi, and I. Mittra (eds.), Proceedings of the International Cancer Congress, Monduzzi Editore, Bologna, pp. 1487-1491.
17. A. Lemus-Wilson, P. A. Kelly, and D. E. Blask (1995). Melatonin blocks the stimulatory effects of prolactin on human breast cancer cell growth in culture. British J. Cancer 72:1435-1440.
18. H. A. Lochnan, H. Buteau, S. Richards, M. Edery, and P. A. Kelley (1995). Functional activity of the human prolactin receptor and its ligands. Mol. Cell. Endocrinol. 114:91-99.
19. N. E. Hynes, N. Cella, and M. Wartmann (1997). Prolactin mediated intracellular signaling in mammary epithelial cells. J. Mam. Gland Biol. Neoplasia 2(1):19-27.
20. J. R. Wicks and C. L. Brooks (1995). Biological activity of phosphorylated and dephosphorylated bovine prolactin. Mol. Cell. Endocrinol. 112:223-229.
21. T. Hoffman, C. Penel, and C. Ronin (1993). Glycosylation of human prolactin regulates hormone bioactivity and metabolic clearance. J. Endocrinol. Invest. 16:807-816.
22. A. E. Price, K. B. Loginenko, E. A. Higgins, E. S. Cole, and S. Richards (1995). Studies on the microheterogeneity and in vitro activity of glycosylated and nonglycosylated recombinant human prolactin separated using a novel purification process. Endocrinology 136:4827-4833.
23. L. Lesueur, M. Edery, S. Ali, J. Paly, P. A. Kelly, and J. Djiane (1991). Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription. Proc. Natl. Acad. Sci. U.S.A. 88:824-828.
24. C. V. Clevenger, W. P. Chang, W. Ngo, T. L. M. Pasha, K. T. Montone, and J. E. Tomaszewski (1995). Expression of prolactin and prolactin receptor in human breast carcinoma. Am. J. Pathol. 146:695-705.
25. V. Goffin and P. A. Kelly (1997). The prolactin/growth hormone receptor family: Structure/function relationships. J. Mam. Gland Biol. Neoplasia 2(1):7-17.
26. 2, and long prolactin receptors. J. Biol. Chem. 269:26076-26082.
27. R. Das and B. K. Vonderhaar (1995). Transduction of prolactin's growth signal through both the long and short forms of the prolactin receptor. Mol. Endocrinol. 9:1750-1759.
28. H. Rui, R. A. Kirken, and W. L. Farrar (1994). Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J. Biol. Chem. 269:5364-5368.
29. 2) cells and mouse mammary gland explants. Proc. Natl. Acad. Sci. U.S.A. 91:5232-5236.
30. I. Dusanter-Fourt, O. Muller, A. Ziemiecki, P. Mayeux, B. Drucker, J. Djiane, A. Wilks, A. G. Harpur, S. Fischer, and S. Gisselbrecht (1994). Identification of JAK protein tyrosine kinases as signaling molecules for prolactin. Functional analysis of prolactin receptor and prolactin-erythropoietin receptor chimera expressed in lymphoid cells. EMBO J. 13:2583-2591.
31. M. J. Waters, N. Daniel, C. Bignon, and J. Dijiane (1995). The rabbit mammary gland prolactin receptor is tyrosine phosphorylated in response to prolactin in vivo and in vitro. J. Biol. Chem. 270:5136-5143.
32. L. DaSilva, H. Rui, R. A. Erwin, O. M. Z. Howard, R. A. Kirken, M. G. Malabarba, R. H. Hackett, A. Lamer, and W. L. Farrar (1996). Prolactin recruits STAT1, STAT3, and STAT5 independent of conserved receptor tyrosine TYR402, TYR479, TYR515, and TYR580. Mol. Cell. Endocrinol. 117:131-140.
33. H. Wakao, F. Gouilleux, and B. Groner (1994). Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J. 13:2182-2191.
34. X. Liu, G. W. Robinson, F. Gouilleux, B. Groner, and L. Hennighausen (1995). Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc. Natl. Acad. Sci. U.S.A. 92:8831-8835.
35. M. David, E. F. Petricoin, K. I. Igarashi, G. M. Feldman, D. S. Finbloom, and A. C. Larner (1994). Prolactin activates the interferon-regulated p91 transcription factor and the JAK2 kinase by tyrosine phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 91:7174-7178.
36. R. Das and B. K. Vonderhaar (1996). Involvement of SHC, Grb2, Sos, and ras in prolactin signal transduction in mammary cells. Oncogens 13:1139-1145.
37. J. E. Darnell Jr., I. M. Kerr, and G. R. Stark (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
38. J. J. Berlanga, J. A. F. Vara, J. Martin-Perez, and J. P. Garcia-Ruiz (1995). Prolactin receptor is associated with c-src kinase in rat liver. Mol. Endocrinol. 9:1461-1467.
39. C. V. Clevenger and M. V. Medaglia (1994). The protein tyrosine kinase p59fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes. Mol. Endocrinol. 8:674-681.
40. C. V. Clevenger, W. Ngo, D. L. Sokol, S. M. Luger, and A. M. Gewirtz (1995). Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line. J. Biol. Chem. 270:13246-13253.
41. S. Ali, Z. Chen, J.-J. Lebrun, W. Vogel, A. Kharitonenkov, P. Kelly, and A. Ullrich (1996). PTP1D is a positive regulator of the prolactin signal leading to β-casein promoter activation. EMBO J. 15:135-142.
42. N. Daniel, M. J. Waters, C. Bignon, and J. Djiane (1996). Involvement of a subset of tyrosine kinases and phosphatases in regulation of the β-lactoglobulin gene promoter by prolactin. Mol. Cell. Endocrinol. 118:25-35.
43. M. Bayat-Sarmadi, C. Puissant, and L. M. Houdebine (1995). The effects of various kinase and phosphatase inhibitors on the transmission of the prolactin and extracellular matrix signals to rabbit α-S1-casein and transferrin genes. Int. J. Biochem. Cell. Biol. 27:707-718.
44. R. A. Erwin, R. A. Kirken, M. G. Malabarba, W. L. Farrar, and H. Rui (1995). Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2 and son of sevenless. Endocrinology 136:3512-3518.
45. 2-11C rat lymphoma cells. Endocrine 4:65-71.
46. R. Das and B. K. Vonderhaar (1996). Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells. Breast Cancer Res. Treat. 40:141-149.
47. C. V. Clevenger, T. Torigoe, and J. C. Reed (1994). Prolactin induces rapid phosphorylation and activation of prolactin receptor-associated Raf-1 kinase in a T-cell line. J. Biol. Chem. 269:5559-5565.
48. R. Piccoletti, P. Maroni, P. Bendinelli, and A. Bernelli-Zazzera (1994). Rapid stimulation of mitogen-activated protein kinase of rat liver by prolactin. Biochem. J. 303:429-433.
49. A. R. Buckley, Y. P. Rao, D. J. Buckley, and P. W. Gout (1994). Prolactin-induced phosphorylation and nuclear translocation of MAP kinase in Nb2 lymphoma cells. Biochem. Biophys. Res. Commun. 204:1158-1164.
50. 2 rat lymphoma cells. J. Cell. Physiol. 167:251-260.
51. 2 lymphoma. Archive Biochem. Biophys. 316:179-189.
52. S. C. Kiley, J. Welsh, C. J. Narvaez, and S. Jaken (1996). Protein kinase C isozymes and substrates in mammary carcinogenesis. J. Mam. Gland Biol. Neoplasia 1:177-187.
53. J. A. Rillema, L. Y. Wing, and K. A. Foley (1983). Effects of phospholipases on ornithine decarboxylase activity in mammary gland explants from midpregnancy mice. Endocrinology 113:2024-2028.
54. 2 node lymphoma cells: the role of protein kinase C and calcium mobilization. Immunopharm. 12:37-51.
55. 2 node lymphoma cells. Proc. Soc. Exp. Biol. 192:140-144.
56. S. B. Waters and J. A. Rillema (1989). Role of protein kinase C in the prolactin-induced responses in mouse mammary gland explants. Mol. Cell. Endocrinol. 63:159-166.
57. A. R. Buckley, P. D. Crowe, and D. H. Russell (1988). Rapid activation of protein kinase C in isolated rat liver nuclei by prolactin. Proc. Natl. Acad. Sci. U.S.A. 85:8649-8653.
58. B. Marquardt, D. Frith, and S. Stabel (1994). Signaling from TPA to MAP kinase requires protein kinase C, raf, and MEK: reconstitution of the signaling pathway in vitro. Oncogene 9:3213-3218.
59. J. VanderKuur, G. Allevato, N. Billestrup, G. Norstedt, and C. Carter-Su (1995). Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2. J. Biol. Chem. 270:7587-7593.
60. M. David, E. Petricoin III, C. Benjamin, R. Pine, M. J. Weber, and A. C. Lamer (1995). Requirement for MAP Kinase (ERK2) activity in Interferon α- and interferon β- stimulated gene expression through STAT proteins. Science 269:1721-1723.
61. X. Zhang, J. Blenis, H. C. Li, C. Schindler, and S. Chen-kiang (1995). Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267:1990-1994.
62. M. T. Zabala and J. P. Garcia-Ruiz (1989). Regulation of expression of the messenger ribonucleic acid encoding the cytosolic form of phosphoenolpyruvate carboxykinase in liver and small intestine of lactating rats. Endocrinology 125:2587-2593.
63. 2 lymphoma cells. Endocrinology 136:5252-5259.
64. A. N. Stevens, Y. Wang, K. A. Sieger, H.-F. Lu, and L. Y. Yu-Lee (1995). Biphasic transcription regulation of the interferon regulatory factor-1 gene by prolactin: Involvement of γ-Interferon-activated sequence and stat-related proteins. Mol. Endocrinol. 9:513-525.
65. E. A. Musgrove, R. Hui, K. J. E. Sweeney, C. K. W. Watts, and R. L. Sutherland (1996). Cyclins and breast cancer. J. Mam. Gland Biol. Neoplasia 1:153-162.
66. P. Sicinski, J. L. Donaher, S. B. Parker, T. Li, A. Fazeli, H. Gardner, S. Z. Haslam, R. T. Bronson, S. J. Elledge, and R. A. Weinberg (1995). Cyclin Dl provides a link between development and oncogenesis in the retina and breast. Cell 82:621-630.
67. 2 cells. Gene 147:249-252.
68. T. C. Wang, R. D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E. V. Schmidt (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin Dl transgenic mice. Nature 369:669-671.